ARCHIVES

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

This article is from The Cancer Letter archive.

Vol. 08 No. 26 | June 25, 1982

Download PDF Visit The Full Archive

Related Articles

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

California approves $3 billion program for stem-cell research.

November 5, 2004

Rabson, Broder Interviewed At White House; Brown Says He Is Not Interested; Sartorelli Not Contracted In Brief: Special Arman Hammer Prize Aimed At Helping Rosenberg Continue His work; DEA Not Moved

November 25, 1988